ADC Therapeutics
ADCT
ADCT
85 hedge funds and large institutions have $182M invested in ADC Therapeutics in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 40 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 82 → 85 (+3)
30% less call options, than puts
Call options by funds: $203K | Put options by funds: $291K
60% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 40
Holders
85
Holding in Top 10
4
Calls
$203K
Puts
$291K
Top Buyers
| 1 | +$16.3M | |
| 2 | +$5.96M | |
| 3 | +$4.77M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$1.95M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$837K |
Top Sellers
| 1 | -$1.37M | |
| 2 | -$825K | |
| 3 | -$353K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$233K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$215K |